本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Aduro Biotech, Inc.

14.60
0.0000
成交量:- -
成交额:- -
市值:2.37亿
市盈率:-3.64
高:14.60
开:14.60
低:14.60
收:14.60
52周最高:20.20
52周最低:4.51
股本:1,621.18万
流通股本:931.67万
量比:- -
换手率:- -
股息:- -
股息率:- -
每股收益(TTM):-4.0052
每股收益(LYR):-5.1411
净资产收益率:-87.44%
总资产收益率:-13.90%
市净率:5.08
市盈率(LYR):-2.84

数据加载中...

2020/06/11

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2020/06/10

企业合并公告

425 - Prospectuses and communications, business combinations
2020/06/10

企业合并公告

425 - Prospectuses and communications, business combinations
2020/06/05

企业合并公告

425 - Prospectuses and communications, business combinations
2020/06/03

企业合并公告

425 - Prospectuses and communications, business combinations
2020/06/02

企业合并公告

425 - Prospectuses and communications, business combinations
2020/06/02

企业合并公告

425 - Prospectuses and communications, business combinations
2020/06/02

企业合并公告

425 - Prospectuses and communications, business combinations
2020/06/02

重要事件披露

8-K - Current report
2020/06/02

企业合并公告

425 - Prospectuses and communications, business combinations
2020/05/06

重要事件披露

8-K - Current report
2020/05/04

重要事件披露

Current report, items 2.02 and 9.01
2020/05/04

季度报告

Quarterly report [Sections 13 or 15(d)]
2020/04/09

重要事件披露

Current report, item 8.01
2020/03/24

重要事件披露

Current report, item 5.02
2020/03/09

员工持股计划

Securities to be offered to employees in employee benefit plans
2020/03/09

重要事件披露

Current report, items 2.02 and 9.01
2020/03/09

年度报告

Annual report [Section 13 and 15(d), not S-K Item 405]
2020/02/12

超过5%披露

Statement of acquisition of beneficial ownership by individuals
2020/02/05

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals